1 matches for your search in the start-up spotlight
rss
matching the following criteria
Sort by:
Ikarovec
Established in 2018, Ikarovec is developing novel, differentiated gene therapies for major ophthalmic indications. Its lead product, a bicistronic gene therapy for geographic atrophy, is in preclinical studies, and earlier programmes are targeting wet-form age-related macular degeneration (AMD), ...
